Please login to the form below

Not currently logged in
Email:
Password:

medicines use

This page shows the latest medicines use news and features for those working in and with pharma, biotech and healthcare.

AZ forecasts growth in 2021 after revenues surge in Q4

AZ forecasts growth in 2021 after revenues surge in Q4

However, AZ did report that the pandemic had a significant impact on certain medicines, including sales of asthma/COPD treatment Pulmicort (budesonide) in China and some decreased use of infused/injectable ... medicines such as Imfinzi and monoclonal

Latest news

More from news
Approximately 0 fully matching, plus 266 partially matching documents found.

Latest Intelligence

  • Growing evidence supports the important role of biosimilars in healthcare Growing evidence supports the important role of biosimilars in healthcare

    Access to healthcare, including affordable medicines, remains a top concern across the US. ... This can help expand options for chronically ill patients and allow greater use of biologic medicines by providing more affordable access to individuals who,

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    The FDA has just granted Roche emergency use authorisation (EUA) for its new test to detect the virus that causes the coronavirus. ... Secondly, the revised Patents Act encourages the development of safe medicinal products for paediatric use.

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    drugs on a trial basis – de-linking the valuation and reward payments from the medicines’ usage. ... by 2024. The plan also supports increased use of a ‘precision medicines’ approach increasing the percentage of prescriptions informed by

  • Keeping up the fight against HIV and using the lessons to tackle other threats Keeping up the fight against HIV and using the lessons to tackle other threats

    of medicines to use. ... We make sure the science is understood and we use that feedback to make sure our medicines are available and used in the right way.

  • The evolution of real-world studies The evolution of real-world studies

    We appreciate that our partnership with the FDA has allowed us to take a significant step forward in the use of real-world data to bring medicines to patients who are ... Real-world data is playing an increasingly important role in expanding the use of

More from intelligence
Approximately 1 fully matching, plus 39 partially matching documents found.

Latest appointments

  • New hires at Bayer, Eisai and Accord Healthcare New hires at Bayer, Eisai and Accord Healthcare

    Prior to joining Accord, Grosso held a number of senior public and commercial roles, including the role of principal medicines management pharmacist at UCL Hospitals. ... Grosso is also a registered pharmacist, and has a long-standing interest in the

  • ABPI Scotland appoints Sandra Auld as director ABPI Scotland appoints Sandra Auld as director

    the access to and use of new and innovative medicines for Scottish patients. . ... and innovative medicines.”.

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    team. “His experience in both government and the pharmaceutical industry will prove invaluable when addressing the issues of access and use of new medicines in the NHS and in leading discussions

  • EAHP elects Joan Peppard as president EAHP elects Joan Peppard as president

    As president of the EAHP, Peppard will look to advance the organisation's mission to develop hospital pharmacy in order to promote the best and safest use of medicines and medical

  • ABPI appoints value and access manager ABPI appoints value and access manager

    Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... greater use of newer medicines,” added Catchpole.

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Let's be ambitious for patients and life sciences investment in Global Britain Let's be ambitious for patients and life sciences investment in Global Britain

    “Take up of new medicines in the UK continues to be slow by international standards”. ... Yet with the sector seen as crucial to economic regeneration post-Brexit and post-pandemic, the slower use of innovative medicines in the UK is a drag anchor on

  • World Ovarian Cancer Day: Current treatments and future hopes for ovarian cancer

    Targeted therapies for ovarian cancer. In 2011, the European Medicines Agency (EMA) approved the use of targeted therapies, including an anti-angiogenic treatment alongside chemotherapy to increase the effectiveness of treatment ... Zejula. Available at:

  • NHS medicines optimisation milestone

    by 2020/21 if the NHS embraces the use of best value biological medicines in a proactive, systematic and safe way’. ... The best biologics agenda and pharma. In line with the Commissioning Framework for Biological Medicines, NHS England, NHS

  • Patient Engagement and Experience Conference, 16-17 May

    The conference brings together HCPs, patients, payers, government, pharma and industry under one roof to focus on patients’ engagement and experience of their treatment to improve the real-world use of ... medicines.Speaking at the conference .

  • "Legal highs" ruling leaves illegal labs laughing

    There is a huge amount of off-label use of licensed medicines by medically qualified prescribers. ... There are also many agents that have crossed the line from illegal to legal use, such as cannabinoids for MS, as well as previously approved medicines

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...
wearable health tech
A cultural shift in clinical research
Research organisations across the board are experimenting with new technologies...

Infographics